Biogaia AB
STO:BIOG B
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
96.2095
134.7
|
Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one BIOG B stock under the Base Case scenario is 106.42 SEK. Compared to the current market price of 106 SEK, Biogaia AB is Fairly Valued.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Biogaia AB
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for BIOG B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Biogaia AB
Balance Sheet Decomposition
Biogaia AB
Current Assets | 1.5B |
Cash & Short-Term Investments | 1.1B |
Other Current Assets | 381.9m |
Non-Current Assets | 408.4m |
Long-Term Investments | 28.1m |
PP&E | 209.9m |
Intangibles | 161.1m |
Other Non-Current Assets | 9.4m |
Current Liabilities | 192.4m |
Other Current Liabilities | 192.4m |
Non-Current Liabilities | 92.8m |
Other Non-Current Liabilities | 92.8m |
Earnings Waterfall
Biogaia AB
Revenue
|
1.4B
SEK
|
Cost of Revenue
|
-358.1m
SEK
|
Gross Profit
|
997.6m
SEK
|
Operating Expenses
|
-597.1m
SEK
|
Operating Income
|
400.5m
SEK
|
Other Expenses
|
-63.7m
SEK
|
Net Income
|
336.8m
SEK
|
Free Cash Flow Analysis
Biogaia AB
SEK | |
Free Cash Flow | SEK |
BIOG B Profitability Score
Profitability Due Diligence
Biogaia AB's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
Score
Biogaia AB's profitability score is 74/100. The higher the profitability score, the more profitable the company is.
BIOG B Solvency Score
Solvency Due Diligence
Biogaia AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Biogaia AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BIOG B Price Targets Summary
Biogaia AB
Dividends
Current shareholder yield for BIOG B is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
BIOG B Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.
Contact
IPO
Employees
Officers
The intrinsic value of one BIOG B stock under the Base Case scenario is 106.42 SEK.
Compared to the current market price of 106 SEK, Biogaia AB is Fairly Valued.